Zoetis (NY:<a title="Quote for Zoetis" href="http://investor.wedbush.com/wedbush/quote?Symbol=NY%3AZTS">ZTS )

In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another...

Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment

December 24, 2025

Don't overlook these potential bargain buys -- they may not stay down for long.

Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. ↗

December 19, 2025

Topics Death

Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From Zoetis Inc.

The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.

These 2 Healthcare Stocks Just Declared Dividend Raises ↗

December 17, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Topics Intellectual Property

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 16, 2025

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 16, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

December 16, 2025

From Zoetis Inc.

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering

December 15, 2025

From Zoetis Inc.

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

December 11, 2025

From Zoetis Inc.

Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.

3 Cash-Producing Stocks with Exciting Potential

December 07, 2025

Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats

December 05, 2025

From Zoetis Inc.

Zoetis exemplifies quality investing with durable competitive strengths, high returns on capital, strong cash flow, and a solid balance sheet.

Zoetis Inc (NYSE:ZTS) Passes the Caviar Cruise Screen for Quality Investing ↗

December 05, 2025

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 02, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Which S&P500 stocks are gapping on Tuesday? ↗

December 02, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast

December 02, 2025

From Zoetis Inc.

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

1 Oversold Stock Primed to Rebound and 2 We Find Risky

December 01, 2025

These companies' prospects are better than recent performances may suggest.

Topics Supply Chain

2 Stocks to Buy Near Their 52-Week Lows ↗

December 01, 2025

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Topics Artificial Intelligence World Trade

November 26, 2025

From Zoetis Inc.

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know

November 21, 2025

U.S. Agriculture Braces for a Tight 2025: The 'Cost-Price Squeeze' Threatens Farm Profitability

Topics Earnings Economy

November 20, 2025

The American agricultural sector is facing a formidable challenge in 2025, as a relentless "cost-price squeeze" threatens to significantly erode farm profitability. This economic vise is tightening...

Topics Climate Change Economy Energy

A Look Into Zoetis Inc's Price Over Earnings ↗

November 20, 2025

Via Benzinga

Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 20, 2025

From Zoetis Inc.

Zoetis’s stock price has taken a beating over the past six months, shedding 28.6% of its value and falling to a new 52-week low of $116.88 per share. This was partly due to its softer quarterly results...

Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?

November 19, 2025

Nashville, TN – November 19, 2025 – Inspire Veterinary Partners, Inc. (NASDAQ: IVP) has been thrust into a precarious financial position, experiencing a staggering -62.27% plummet in its stock value...

Inspire Veterinary Partners Plunges Over 60% as Nasdaq Delisting Looms

November 19, 2025

Topics Supply Chain

Zoetis to Host Innovation Webcast

November 19, 2025

From Zoetis Inc.

These cheap dividend stocks would make great cornerstone pieces to any portfolio -- especially for investors looking for a deal in today's somewhat expensive market.

2 Outstanding Dividend Stocks That Are Too Cheap to Ignore ↗

November 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

November 12, 2025

These healthcare heavyweights have tumbled, causing abnormally high dividend yields.

Topics Stocks

2 Dividend Stocks to Double Up on Right Now ↗

November 11, 2025

Zoetis faced a challenging third quarter, with the market reacting negatively to results that showed flat year-on-year sales and a trim to full-year revenue guidance. Management attributed the muted...

The 5 Most Interesting Analyst Questions From Zoetis’s Q3 Earnings Call

November 11, 2025